Evaluation of Ambulatory ECG Telemetry for the Early Detection of Atrial Fibrillation During Hospital Assessment of Cerebral Infarction

Hopital Foch1 site in 1 country8 target enrollmentDecember 27, 2018

ConditionsCerebral Infarction

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Cerebral Infarction
Sponsor: Hopital Foch
Enrollment: 8
Locations: 1
Primary Endpoint: Diagnostic impact of outpatient ECG telemetry
Status: Terminated
Last Updated: 6 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

The aim of the study is to show that an ambulatory ECG telemetry monitoring of some patients hospitalized for cerebral infarction increases the frequency of the diagnosis of atrial fibrillation, cause of their stroke, and reinforces the protection against recurrences.

Registry

clinicaltrials.gov

Start Date

December 27, 2018

End Date

July 3, 2019

Last Updated

6 years ago

Study Type

Interventional

Study Design

Parallel

Sex

All

Investigators

Sponsor

Hopital Foch

Responsible Party

Sponsor

Eligibility Criteria

Inclusion Criteria

•Patients over 18 years old
•Diagnosis of transient ischemic or cerebral accident
•Absence of etiological orientation after the initial assessment (including at least cerebral MRI, angiography of the supra aortic trunks by CT or MRI, echocardiography with search for patent foramen ovale, standard biology)
•Affiliated to a social security system.
•Having given no opposition to participation in research

Exclusion Criteria

•AF known or diagnosed during stay in USINV

Outcomes

Primary Outcomes

Diagnostic impact of outpatient ECG telemetry

Time Frame: 6 months

Percentage of patients hospitalized for cerebral infarction and with a diagnosis of atrial fibrillation allowed by the use of ambulatory ECG telemetry.

Secondary Outcomes

Evaluate the benefit on the recurrence rate of cerebral infarction after the exit of the service(3 months)
Evaluate the therapeutic impact (prescription anticoagulant) at the end of hospitalisation(6 months)
Identification of prognostic factors to identify de novo atrial fibrillation(6 months)